Moleculin Announces Reverse Stock Split

Yahoo Finance Published Updated Stocks
Sign in to save

Affected assets and topics

NASDAQ MARKET TRADING

Why it matters

Moleculin Biotech announced a 1-for-25 reverse stock split, effective December 1, 2025, to increase the stock's trading value and potentially improve its market standing.

Article tone

Neutral How the article is written, as reported by the source.

Expected market reaction

Neutral Confidence 71% How confidence is read Impact: Moderate

Market impact analysis based on neutral sentiment with 71% confidence.

Evidence trail

Evidence
Source Yahoo Finance
Claim Moleculin Announces Reverse Stock Split
AI inference Neutral · 71%
Generated 2025-11-26 14:00

AI provenance

Analysed by Llama 3.1 8B Instant (Groq) Methodology v1.0 Generated
Technical identifiers
Provider tag
groq-llama-3.1-8b-instant
Analysis version
groq-llama-3.1-8b-instant
Article id
15345

Original source

HOUSTON, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that it filed an amendment to its amended and restated certificate of incorporation with the Secretary of State of the State of Delaware to effect a 1-for-25 reverse stock split of its common stock. The reverse stock split will take effect at 12:01 am (Eastern Time) on December 1, 2025, and the Company’s common stock will open for trading on The Nasdaq Capital Market

Read the full article on Yahoo Finance

Original article published by Yahoo Finance on November 26, 2025. Analysis and insights provided by AnalystMarkets AI.

Related coverage